NeueHealth (NEUE) Stock Price, News & Analysis

Company Overview

NeueHealth (NYSE:NEUE) is a healthcare services company specializing in value-based care solutions for Medicare Advantage and employer-sponsored health plans. Through an integrated platform, the company offers care coordination, risk analytics, member engagement tools and home-based clinical services designed to improve patient outcomes and control total cost of care. Its solutions are delivered in partnership with health insurers, providers and third-party administrators, enabling seamless data sharing and streamlined operational workflows.

Founded in the late 2010s and headquartered in the United States, NeueHealth has rapidly expanded its footprint across multiple regional markets, including key states such as California, Texas, Florida and select Midwestern and Northeastern territories. The company’s network of affiliated primary care practices, home-visit clinicians and specialty partnerships allows it to tailor care models to local populations while leveraging centralized technology to monitor clinical and financial performance. This hybrid approach supports both traditional fee-for-service arrangements and fully capitated value-based contracts.

Central to NeueHealth’s offerings is its proprietary digital engagement platform, which facilitates virtual visits, remote monitoring and personalized care plans. Complementing this technology is a team of in-home clinicians who serve high-risk and chronically ill members, reducing hospital admissions and improving medication adherence. By combining data-driven insights with hands-on care interventions, the company aims to deliver a more proactive and preventive healthcare experience.

NeueHealth’s leadership team brings together executives with extensive experience in managed care, technology and retail health. The company emphasizes strategic partnerships with payers and health systems to pilot innovative payment models and expand its service lines. As it continues to scale, NeueHealth is focused on broadening its geographic reach and deepening its capabilities in specialty populations, behavioral health integration and social determinants of health initiatives.

Key Stats

• Today's Range: $6.81 to $6.87
• 50-Day Range: $6.74 to $6.95
• 52-Week Range: $3.79 to $7.66
• Volume: 6,572 shs
• Average Volume: 18,618 shs
• Market Capitalization: $60.81 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $7.00
• Consensus Rating: Hold

NeueHealth Stock Analysis - MarketRank™

NeueHealth scored higher than 18% of companies evaluated by MarketBeat, and ranked 870th out of 933 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.0 / 5
• Analyst Rating: Hold

Consensus Rating

NeueHealth has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

NeueHealth has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for NeueHealth are expected to grow in the coming year, from ($9.13) to ($9.01) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of NeueHealth is -0.31, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of NeueHealth is -0.31, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.39% of the float of NeueHealth has been sold short.

Short Interest Ratio / Days to Cover

NeueHealth has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in NeueHealth has recently increased by 103.03%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

NeueHealth does not currently pay a dividend.

Dividend Growth

NeueHealth does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.39% of the float of NeueHealth has been sold short.

Short Interest Ratio / Days to Cover

NeueHealth has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in NeueHealth has recently increased by 103.03%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: 0.00

News Coverage This Week

MarketBeat has tracked 3 news articles for NeueHealth this week, compared to 1 article on an average week.

Company Ownership

• Score: 4.2 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, NeueHealth insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $3,948.00 in company stock.

Percentage Held by Insiders

63.30% of the stock of NeueHealth is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

63.88% of the stock of NeueHealth is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

NEUE Stock Analysis - Frequently Asked Questions

How have NEUE shares performed this year?

NeueHealth's stock was trading at $7.42 at the beginning of the year. Since then, NEUE shares have decreased by 8.2% and is now trading at $6.81.

How were NeueHealth's earnings last quarter?

NeueHealth, Inc. (NYSE:NEUE) announced its earnings results on Thursday, May, 8th. The company reported ($1.80) earnings per share for the quarter, topping the consensus estimate of ($2.51) by $0.71. The company had revenue of $215.79 million for the quarter, compared to the consensus estimate of $249.50 million.
Read the conference call transcript.

How do I buy shares of NeueHealth?

Shares of NEUE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of NeueHealth own?

Based on aggregate information from My MarketBeat watchlists, some other companies that NeueHealth investors own include Jiuzi (JZXN), ARMOUR Residential REIT (ARR), Aethlon Medical (AEMD), Aditxt (ADTX), Ainos (AIMD), Adial Pharmaceuticals (ADIL) and Avalon GloboCare (ALBT).

Company Calendar

• Last Earnings: 5/08/2025
• Today: 7/19/2025
• Next Earnings (Estimated): 8/07/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Medical Services
• Sub-Industry: Insurance
• Current Symbol: NYSE:NEUE
• Previous Symbol: NYSE:NEUE
• CIK: 1671284
• Web: www.brighthealthgroup.com
• Phone: 612-238-1321
• Fax: N/A
• Employees: 1,252
• Year Founded: N/A

Price Target and Rating

• Average Price Target for NeueHealth: $7.00
• High Price Target: $7.00
• Low Price Target: $7.00
• Potential Upside/Downside: +2.8%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Trailing Twelve Months): ($22.00)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$134.68 million
• Net Margins: -14.28%
• Pretax Margin: -11.81%
• Return on Equity: N/A
• Return on Assets: -17.46%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.74
• Quick Ratio: 0.74

Sales & Book Value

• Annual Sales: $936.66 million
• Price / Sales: 0.06
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($163.57) per share
• Price / Book: -0.04

Miscellaneous

• Outstanding Shares: 8,930,000
• Free Float: 3,277,000
• Market Cap: $60.81 million
• Optionable: N/A
• Beta: 0.57